Video Experimental Relacionado
Updated: Jan 23, 2026
08:17
Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
11.5K
Proteómica y fosfoproteómica del esputo para mejorar el conocimiento de la enfermedad pulmonar obstructiva crónica
Fei Long1, Xiaoyin Zeng2, Fengyan Wang3
1Sino-French Hoffmann Institute, State Key Laboratory of Respiratory Disease, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, China.
Journal of proteomics
|January 21, 2026
Resumen
Este estudio muestra que el esputo inducido en bruto es una fuente valiosa para la biopsia líquida en enfermedades respiratorias como la EPOC. El método de preparación de muestras asistida por filtro mejoró la identificación de proteínas para un análisis integral de la enfermedad.
Área de la Ciencia:
- Proteómica y fosfoproteómica
- Investigación de enfermedades respiratorias
- Descubrimiento de biomarcadores
Sus antecedentes:
- El análisis del esputo inducido ofrece información sobre las enfermedades respiratorias.
- Los enfoques proteómicos y fosfoproteómicos son cruciales para comprender la patología de la enfermedad.
- Los métodos actuales para el análisis del esputo requieren optimización para un perfil molecular integral.
Objetivo del estudio:
- Evaluar el esputo inducido en bruto como fuente de biopsia líquida en la enfermedad pulmonar obstructiva crónica (EPOC).
- Establecer y evaluar métodos de análisis proteómico y fosfoproteómico para muestras de esputo.
- Crear un mapa preliminar del proteoma y fosfoproteoma de la EPOC.
Principales métodos:
- Se recolectaron muestras de esputo inducido de pacientes con EPOC.
- Se realizó un análisis proteómico y fosfoproteómico utilizando tres métodos de digestión enzimática: in-gel, in-solution y preparación de muestras asistida por filtro (FASP).
- Se comparó la eficacia de diferentes métodos de digestión para la identificación de proteínas y fosfoproteínas.
Principales resultados:
- Las muestras de esputo en bruto produjeron un mayor número de proteínas y fosfoproteínas identificadas en comparación con las muestras procesadas.
- El método FASP aumentó la identificación de proteínas en aproximadamente un 30% y proporcionó el mayor número de identificaciones de proteínas únicas.
- Se generó un mapa preliminar del proteoma y fosfoproteoma del esputo de la EPOC, identificando vías biológicas relevantes.
Conclusiones:
- El esputo inducido en bruto es una fuente viable e integral para la biopsia líquida en enfermedades respiratorias.
- El método FASP es superior para el análisis proteómico y fosfoproteómico del esputo.
- Este estudio proporciona un marco metodológico y un conjunto de datos para la proteómica del esputo, ofreciendo información sobre la patología de la EPOC.
Videos de Conceptos Relacionados
01:22Chronic Obstructive Pulmonary Disease
2.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.3K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.6K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.6K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.3K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.3K
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
5.1K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
5.1K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.6K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.6K